Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

A. B. Gottlieb, C. Leonardi, F. Kerdel, S. Mehlis, M. Olds, D. A. Williams

Research output: Contribution to journalArticlepeer-review

115 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science